Literature DB >> 24453649

Transdermal monosialoganglioside with laser in the treatment of spinal cord lesion in rats.

Fabiano Inácio de Souza1, Alexandre Fogaça Cristante1, Raphael Martus Marcon1, Ricardo Ferreira1, Gustavo Bispo Dos Santos1, Tarcísio Eloy Pessoa de Barros Filho1.   

Abstract

OBJECTIVES: To evaluate the effects of monosialoganglioside (GM1) administered transdermally with laser in the recovery of spinal cord injury in rats.
METHODS: Forty male Wistar rats underwent spinal cord contusion using the NYU Impactor. In Group 1, the rats received 0,2 ml of saline intraperitoneally daily; in Group 2, GM1 was administered intraperitoneally at a concentration of 30 mg/kg per day; in Group 3, rats were treated daily with laser at low temperature on the skin, and in Group 4, the daily laser session also contained GM1. All the groups were treated for 42 days. The animals were evaluated by the Basso, Baettie and Bresnahan (BBB) functional scale on days 7, 14, 21, 28, 35 and 42 after the injury, and by histopathology and motor evoked potential after 42 days of injury.
RESULTS: The animals in Group 4 had higher BBB scores compared with the other groups. There were no differences between the groups, or in the comparisons over time. Histological evaluation showed no differences, and no differences were found in the motor evoked potential tests either.
CONCLUSION: GM1 associated with the use of low-temperature laser shows no superior functional, neurological or histological results in the treatment of spinal cord lesions in rats. Evidence Level I, Experimental, Controlled, Animal Study.

Entities:  

Keywords:  Contusions; G(M1) ganglioside; Lasers; Spinal cord injuries

Year:  2013        PMID: 24453649      PMCID: PMC3861964          DOI: 10.1590/S1413-78522013000200004

Source DB:  PubMed          Journal:  Acta Ortop Bras        ISSN: 1413-7852            Impact factor:   0.513


  15 in total

Review 1.  Proteins and peptides: strategies for delivery to and across the skin.

Authors:  Heather A E Benson; Sarika Namjoshi
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

Review 2.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

3.  Potentializing the effects of GM1 by hyperbaric oxygen therapy in acute experimental spinal cord lesion in rats.

Authors:  R M Marcon; A F Cristante; T E P de Barros Filho; R P de Oliveira; G B dos Santos
Journal:  Spinal Cord       Date:  2010-04-27       Impact factor: 2.772

4.  Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production.

Authors:  Y Taoka; K Okajima; M Uchiba; M Johno
Journal:  J Neurotrauma       Date:  2001-05       Impact factor: 5.269

5.  Clinical application of modest hypothermia after spinal cord injury.

Authors:  Allan D Levi; Barth A Green; Michael Y Wang; W Dalton Dietrich; Ted Brindle; Steven Vanni; Gizelda Casella; Gina Elhammady; Jonathan Jagid
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

6.  Antioxidative therapy in contusion spinal cord injury.

Authors:  A F Cristante; T E P Barros Filho; R P Oliveira; R M Marcon; I D Rocha; F R Hanania; K Daci
Journal:  Spinal Cord       Date:  2008-12-09       Impact factor: 2.772

7.  Neuroprotective effect of moderate epidural hypothermia after spinal cord injury in rats.

Authors:  Kee-Yong Ha; Young-Hoon Kim
Journal:  Spine (Phila Pa 1976)       Date:  2008-09-01       Impact factor: 3.468

8.  Hypothermia for spinal cord injury.

Authors:  Brian K Kwon; Cody Mann; Hong Moon Sohn; Alan S Hilibrand; Frank M Phillips; Jeffrey C Wang; Michael G Fehlings
Journal:  Spine J       Date:  2008-03-10       Impact factor: 4.166

Review 9.  Gangliosides for acute spinal cord injury.

Authors:  P Chinnock; I Roberts
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

10.  Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis.

Authors:  Márcio Oliveira Penna Carvalho; Tarcisio Eloy Pessoa de Barros Filho; Marcos Antonio Tebet
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more
  4 in total

Review 1.  GM1 Ganglioside: Past Studies and Future Potential.

Authors:  Massimo Aureli; Laura Mauri; Maria Grazia Ciampa; Alessandro Prinetti; Gino Toffano; Cynthia Secchieri; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

2.  Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer.

Authors:  Laura Terraneo; Paola Bianciardi; Eleonora Virgili; Elena Finati; Michele Samaja; Rita Paroni
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Neuroprotective effect of epidural hypothermia after spinal cord lesion in rats.

Authors:  Marcello Oliveira Barbosa; Alexandre Fogaça Cristante; Gustavo Bispo Dos Santos; Ricardo Ferreira; Raphael Martus Marcon; Tarcisio Eloy Pessoa de Barros Filho
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

4.  THE EFFECT OF MONOSIALOGANGLYOSIDE (GM-1) ADMINISTRATION IN SPINAL CORD INJURY.

Authors:  Tarcísio Eloy Pessoa Barros; Fernando Flores De Araujo; Lucas Da Paz Higino; Raphael Martus Marcon; Alexandre Fogaça Cristante
Journal:  Acta Ortop Bras       Date:  2016 May-Jun       Impact factor: 0.513

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.